These compounds may interact with:
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Potentially involved in: carcinoma; pontocerebellar hypoplasia; acute myeloid leukemia; diabetes mellitus; down syndrome; multiple myeloma; osteosarcoma; ovarian cancer; pituitary cancer; waldenstrons macroglobulinemia
Disease data sourced from Pharos.